SARS-CoV-2 Omicron Variant is Expected to Retain Most of the Spike Protein Specific Dominant T-Cell Epitopes Presented by COVID-19 Vaccines — Worldwide, 2021

    FullText(HTML)
  • loading
    • References (10)
    • Related Articles
  • Jiajing Jiang, Yingying Du, Tao Peng. SARS-CoV-2 Omicron Variant is Expected to Retain Most of the Spike Protein Specific Dominant T-Cell Epitopes Presented by COVID-19 Vaccines — Worldwide, 2021J. China CDC Weekly, 2022, 4(18): 381-384. DOI: 10.46234/ccdcw2022.065
    Citation: Jiajing Jiang, Yingying Du, Tao Peng. SARS-CoV-2 Omicron Variant is Expected to Retain Most of the Spike Protein Specific Dominant T-Cell Epitopes Presented by COVID-19 Vaccines — Worldwide, 2021J. China CDC Weekly, 2022, 4(18): 381-384. DOI: 10.46234/ccdcw2022.065
    shu

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return